ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Multivalent peptide dendrimers inhibit the fusion of viral-cellular membranes and the cellular NF-κB signaling pathway

Xie, Xi; He, Jian*广州医学院; 南方医科大学
European Journal of Medicinal Chemistry2022-2-15DOI: 10.1016/j.ejmech.2022.114140
4被引9阅读
引用收藏
分享

摘要

The binding of the influenza A virus (IAV) to host cells is multivalent interactions between the hemagglutinin (HA) trimer and sialic acid residues on the cell surface, which present a challenge for the development of efficient antiviral drugs interfering with the entry of IAV into host cells. In this study, a number of multivalent peptide dendrimers targeting the HA2 subunit of HA to block the fusion between viral-cellular membranes have been created, of which FMOC-4-KKWK showed the lowest cytotoxicity, while in the nanomolar concentration range of antiviral effects. In addition to being active against a panel of various subtypes of influenza viruses, these dendrimers reduced the levels of NF-kappa B in RAW 264.7 cells and inhibited the overexpression of proinflammatory cytokines of TNF-alpha, IL-1 beta, and IL-6 that are associated with the influenza infection. Further tests in mice infected with a lethal dose of PR8 virus showed that these dendrimers increased the survival rate of mice, and reduced the viral load in the lungs. Significantly, this is the first report describing peptide dendrimers that target the HA2 subunit of IAV, differing from those using carbohydrates as ligands to block the adsorption of viruses to host cells.

学科与关键词

关键词
Influenza A virusesMultivalent interactionPeptide dendrimersMultiple functions
相关
加载中…
  • A "building block" approach to the new influenza A virus entry inhibitors with reduced cellular toxicities
    Lin Dongguo; Li Fangfang; Wu Qiuyi; Xie Xiangkun; Wu Wenjiao; Wu Jie; Chen Qing; Liu Shuwen; He Jian*Scientific Reports, 2016, 6: 22790.
  • Phenolic compound SG-1 from Balanophora harlandii and its derivatives exert anti-influenza A virus activity via activation of the Nrf2/ HO-1 pathway
    Zhou, Runhong; Hu, Jianan; Qiu, Jingnan; Lu, Shengsheng; Lin, Haixing; Huang, Ruifeng; Zhou, Shaofen; Huang, Guoqing; He, Jian*Biochemical Pharmacology, 2023, 210: 115495.
  • Emerging and state of the art hemagglutinin-targeted influenza virus inhibitors.
    Zhang, Qiao; Liang, Taizhen; Nandakumar, Kutty Selva; Liu, Shuwen*EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22(6): 715-728.被引 15
查看全部 →

发表信息

论文状态
公开发表
期刊
European Journal of Medicinal Chemistry
发表日期
2022-02-15
卷期
第 230 卷
页码
114140
DOI
10.1016/j.ejmech.2022.114140
语言
MULTI-LANGUAGE
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81773556]; China, Science and Technology Department of Guangdong Province of China [2015A020211010]; Southern Medical University [B1040903]

作者

  • X

    Xie, Xi (第一作者)

    guangzhou med univ · southern med univ

  • H

    He, Jian (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417